{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:45:37Z","timestamp":1773020737550,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yebeh.2019.106466","type":"journal-article","created":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T10:49:02Z","timestamp":1566730142000},"page":"106466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"PB","title":["Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"101","author":[{"given":"Francesco","family":"Brigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Del Giovane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.106466_bb0005","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2014report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.106466_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1528-1167.2005.00409.x","article-title":"Mortality after a first episode of status epilepticus in the United States and Europe","volume":"46","author":"Logroscino","year":"2005","journal-title":"Epilepsia."},{"key":"10.1016\/j.yebeh.2019.106466_bb0015","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2019.106466_bb0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/14656566.2016.1127354","article-title":"Pharmacologic treatment of status epilepticus","volume":"17","author":"Trinka","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2019.106466_bb0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/ene.13560","article-title":"A critical appraisal of randomized controlled trials on intravenous phenytoin in convulsive status epilepticus","volume":"25","author":"Brigo","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2019.106466_bb0030","article-title":"Anticonvulsant therapy for status epilepticus","volume":"9","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2019.106466_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.yebeh.2019.106466_bb0040","series-title":"Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]","author":"Cochrane","year":"2011"},{"key":"10.1016\/j.yebeh.2019.106466_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jrsm.1037","article-title":"Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool","volume":"3","author":"Salanti","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.yebeh.2019.106466_bb0050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.7326\/0003-4819-159-2-201307160-00008","article-title":"Conceptual and technical challenges in network meta-analysis","volume":"159","author":"Cipriani","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.yebeh.2019.106466_bb0055","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2019.106466_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.yebeh.2019.106466_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.951","article-title":"Sodium valproate compared to phenytoin in treatment of status epilepticus","volume":"8","author":"Amiri-Nikpour","year":"2018","journal-title":"Brain Behav"},{"key":"10.1016\/j.yebeh.2019.106466_bb0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure."},{"key":"10.1016\/j.yebeh.2019.106466_bb0075","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jocn.2014.12.013","article-title":"Levetiracetam versus phenytoin in management of status epilepticus","volume":"22","author":"Chakravarthi","year":"2015","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.yebeh.2019.106466_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yebeh.2017.07.005","article-title":"Comparison of lacosamide versus sodium valproate in status epilepticus: a pilot study","volume":"76","author":"Misra","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106466_bb0085","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1468-1331.2011.03420.x","article-title":"Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study","volume":"18","author":"Chen","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2019.106466_bb0090","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40263-016-0388-6","article-title":"Phenobarbital versus valproate for generalized convulsive status epilepticus in adults: a prospective randomized controlled trial in China","volume":"30","author":"Su","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2019.106466_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2016.09.020","article-title":"Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106466_bb0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yebeh.2016.09.030","article-title":"Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus","volume":"64","author":"Brigo","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.106466_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1684\/epd.2013.0601","article-title":"A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus","volume":"15","author":"Brigo","year":"2013","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2019.106466_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ane.13025","article-title":"Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis","volume":"139","author":"Lattanzi","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.106466_bb0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2019.106466_bb0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/fnl-2018-0011","article-title":"Intravenous phenytoin in convulsive status epilepticus: the devil we (think we) know","volume":"13","author":"Brigo","year":"2018","journal-title":"Future Neurol"},{"key":"10.1016\/j.yebeh.2019.106466_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eplepsyres.2016.08.006","article-title":"A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy","volume":"127","author":"Brigo","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.106466_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2013.12.007","article-title":"The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies","volume":"23","author":"Yasiry","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.106466_bb0135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.annemergmed.2014.04.017","article-title":"What is the best first-line agent for benzodiazepine-resistant convulsive status epilepticus?","volume":"64","author":"Berkowitz","year":"2014","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.yebeh.2019.106466_bb0140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1528-1167.2011.03237.x","article-title":"Established status epilepticus treatment trial (ESETT)","volume":"52","author":"Cock","year":"2011","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019304251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019304251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T03:53:49Z","timestamp":1719978829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019304251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":28,"alternative-id":["S1525505019304251"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106466","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous antiepileptic drugs in adults with benzodiazepine-resistant convulsive status epilepticus: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.106466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106466"}}